Hydrochloric Acid → 1-Methyl-4-[({[4-(trifluoromethoxy)phenyl]amino}carbonyl)amino]-1H-imidazole-2-carboxylic Acid
反応式
C([O:3][C:4]([C:6]1[N:7]([CH3:26])[CH:8]=[C:9]([NH:11][C:12]([NH:14][C:15]2[CH:20]=[CH:19][C:18]([O:21][C:22]([F:25])([F:24])[F:23])=[CH:17][CH:16]=2)=[O:13])[N:10]=1)=[O:5])C.[OH-].[Na+].Cl>C(O)C.O1CCCC1>[CH3:26][N:7]1[CH:8]=[C:9]([NH:11][C:12]([NH:14][C:15]2[CH:20]=[CH:19][C:18]([O:21][C:22]([F:23])([F:25])[F:24])=[CH:17][CH:16]=2)=[O:13])[N:10]=[C:6]1[C:4]([OH:5])=[O:3]参加物
6
反応物 3
生成物 1
試薬・触媒・溶媒 2
実験手順
835 mg (2.13 mmol) of 1-methyl-4-[({[4-(trifluoromethoxy)phenyl]-amino}carbonyl)amino]-1H-imidazole-2-carboxylic acid ethyl ester (Example 3A) is suspended in 5 ml of ethanol and 12 ml of tetrahydrofuran. While being cooled with ice, 2 ml (25 mmol) of 50% aqueous sodium hydroxide solution is added. The reaction mixture is stirred overnight at room temperature and then made acidic with 1N hydrochloric acid while being cooled with ice. The solution is extracted with dichloromethane. The organic phase is concentrated by evaporation in a vacuum. The residue is purified by preparative HPLC.
後処理
- additionis added
- temperaturewhile being cooled with ice
- extractionThe solution is extracted with dichloromethane
- concentrationThe organic phase is concentrated by evaporation in a vacuum
- customThe residue is purified by preparative HPLC
出典と根拠
- ORDレコード
- ord-1661679caa5c46de99a31372b2624242
- 出典データセット
- uspto-grants-2015_09
- 特許番号
- US09133165B2
反応ノート
読み込み中…